MedTrace Logo

High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth

NCT06550089 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2024-12-10

No results posted yet for this study

Summary

This is a study to investigate whether it is feasible to conduct a randomized controlled trial (RCT) of a high dose of oxytocin versus the standard low-dose oxytocin. Further the investigators, aim to assess whether there are differences in health outcomes between both arms of the study.

Conditions

  • Postpartum Hemorrhage
  • Pregnancy Complications
  • Cesarean Section Complications

Interventions

DRUG

Oxytocin

Oxytocin is a synthetic molecule used to reduce the likelihood of postpartum hemorrhage.

Sponsors & Collaborators

  • Medical College of Wisconsin

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Ashish Premkumar, MD, PhD · University of Chicago

  • Anna Palatnik, MD · Medical College of Wisconsin

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2026-10-31
Completion
2026-12-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06550089 on ClinicalTrials.gov